Transcatheter Aortic Valve Replacement for Failed Transcatheter Aortic Valve

San Donato Group (GSD)

Status: Completed

Conditions: Failed Transcather Aortic Valve

Treatments: Device: TAVR

Study type: Observational

Funder types: Other

Identifiers

NCT04500964

TRANSIT

Details and patient eligibility

About

Patients with failed transcather aortic valve (stenotic, regurgitant, both) and indication to further transcatheter aortic valve replacement (TAVR).

The purpouse of this study is to evaluate the indication to a second TAVR, the selection criteria of the second transcatheter aortic valve, procedural and clinical outcomes.

The primary endpoint of the study is overall mortality and Cardiovascular mortality at 1 year

Enrollment: 173 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with failed transcather aortic valve (stenotic, regurgitant, both) and indication to further transcatheter aortic valve replacement (TAVR).

Exclusion criteria

Trial design

173 participants in 3 patient groups

failed transcather aortic valve (Stenotic)

Treatment:

Device: TAVR

failed transcather aortic valve (Regurgitation)

Treatment:

Device: TAVR

failed transcather aortic valve (Regurgitation and stenotic))

Treatment:

Device: TAVR